Product Program year 2025 Source: CMS Open Payments

Visiglide

Device EndoTherapy

PDI 04953170282744

Open in the dashboard

General payments

$1,222,675

793 payments

Research payments

$0

0 payments

Through program year 2025, $1,222,675 in general payments and $0 in research payments were reported against Visiglide (EndoTherapy).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $511,731 314
2024 General $710,944 479

Breakdown

Who paid General payments · program years 2024–2025
  1. Olympus Corporation of the Americas $1,044,591 183 payments
  2. Olympus America Inc. $178,009 607 payments
  3. Olympus Latin America, Inc. $75 3 payments
Top recipients General payments · program year 2025
  1. Cedars-Sinai Medical Center Teaching hospital · CA $160,885 31% · 1 payment
  2. Adventhealth Orlando Teaching hospital · FL $137,759 27% · 1 payment
  3. Mercy Medical Center Teaching hospital · MD $90,987 18% · 1 payment
  4. Muhammad Hasan Gastroenterology · Orlando, FL $19,196 4% · 12 payments
  5. Koushik Das Gastroenterology · Saint Louis, MO $16,991 3% · 14 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Gastroenterology Internal Medicine $120,161 99% · 160 practitioners
  2. Internal Medicine $504 <1% · 9 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $192 <1% · 7 practitioners
  4. Nurse Practitioner $179 <1% · 4 practitioners
  5. Colon & Rectal Surgery $126 <1% · 3 practitioners

The top 5 of 19 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $173,729 34% · 48 recipients
  2. Florida $163,575 32% · 7 recipients
  3. Maryland $98,283 19% · 9 recipients
  4. Missouri $16,991 3% · 1 recipient
  5. New Jersey $14,603 3% · 8 recipients

The top 5 of 30 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

793 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record